Vitality Watch

Dossier pubmed review 29-jul-2026
Narrative review or expert overview without new data

Complosome as a key modulator of cellular senescence, aging and age-related diseases.

Key claim: Intracellular complement (the complosome), especially intC3/intC5, crosstalks with mTOR, NF-κB, and AMPK to modulate cellular senescence, inflammaging, and multiple hallmarks of aging, and is a candidate target for age-related disease interventions.

Abstract

Aging is characterized by progressive physiological decline and accumulation of senescent cells that drive chronic “inflammaging” through the senescence-associated secretory phenotype (SASP). The complement system, traditionally viewed as a systemic extracellular defense mechanism, is now recognized as an essential intracellular network (the complosome). This review synthesizes current research on how intracellular C3 (intC3), and intracellular C5 (intC5) in certain contexts engage in extensive crosstalk with the mTOR, NF-κB, and AMPK pathways to modulate core cellular processes. We detail how intC3 intersects with multiple canonical hallmarks of aging-including cellular senescence, mitochondrial dysfunction, proteostasis loss, genomic instability, epigenetic alterations, altered intercellular communication, stem cell exhaustion, and deregulated nutrient sensing. Furthermore, we examine organ-specific consequences of intC3 dysregulation across the aging brain, liver, eye, kidney, vasculature, lung, and immune system, as well as cancer. Finally, we discuss therapeutic strategies-including complement inhibitors, senolytics, senomorphics, RNA interference, proteolysis targeting chimeras (PROTACs), and nanotechnology-enabled delivery-and outline critical gaps in compartment-specific tools, conditional knockouts, and longitudinal models. Precision strategies that preserve systemic complement function while selectively modulating intracellular pools will be essential to translate complosome biology into durable interventions for age-related diseases.

Why this matters

The complosome reframes complement — long treated as an extracellular innate-immune system — as a cell-intrinsic regulatory hub that intersects the mTOR/NF-κB/AMPK core of aging biology, potentially unifying senescence, inflammaging, and mitochondrial decline under a single upstream node. It is a synthesis-level claim rather than a primary readout, so it currently expands the mechanistic map and startup-target menu without moving human translation forward.

Source

Link

Briefing card

Complosome as a key modulator of cellular senescence, aging and age-related diseases.
Stage: review · pubmed · 29-jul-2026

Intracellular complement (the complosome), especially intC3/intC5, crosstalks with mTOR, NF-κB, and AMPK to modulate cellular senescence, inflammaging, and multiple hallmarks of aging, and is a candidate target for age-related disease interventions.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103274

build build 880 · 2bcef25 · 2026-11-18